Fierce Biotech News & Reports
WEBBiopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on Fierce Biotech as their must-read source for the latest news, analysis and data in the world of biotech ...
MedTech | Fierce Biotech
WEB6 days ago · A paper on the methods being used in the clinical study, named ADAPT-PD, was published this week in the Nature journal npj Parkinson’s Disease. Conor Hale Sep 18, 2024 12:15pm. Connect. The Team.
Biotech | Fierce Biotech
WEBAug 20, 2024 · The network will focus on familiar virus families to build knowledge that can be transferred to related pathogens as they emerge. Darren Incorvaia Sep 18, 2024 5:24pm. Connect.
FDA clears first non-drug fibromyalgia treatment - Fierce Biotech
WEBMay 19, 2022 · The Quell device received an initial 510(k) clearance from the FDA in 2014, when it was indicated as an over-the-counter treatment for chronic pain—without a specific focus on fibromyalgia ...
Eli Lilly opens $700M nucleic acid R&D center in Boston Seaport
WEBAug 13, 2024 · Eli Lilly Boston DNA Dave Ricks. Eli Lilly has opened a $700 million R&D center in the Boston Seaport, boosting its RNA and DNA research capabilities and expanding its biotech-hosting Gateway Labs ...
Amgen axes an obesity asset, zooms in on MariTide - Fierce Biotech
WEBBy Gabrielle Masson May 2, 2024 6:16pm. Amgen Obesity obesity drugs Eli Lilly. Amgen is axing obesity candidate AMG 786 and going all in on later-stage asset MariTide. “Given the profile we've ...
Genentech to close cancer immunology research department
WEBBy Angus Liu Aug 16, 2024 11:08am. Roche Genentech immuno-oncology layoffs. Genentech will close its cancer immunology research department, and unit head and renowned cell biologist Ira Mellman ...
Grail delivers final study results showing its blood test's accuracy in ...
WEBJun 25, 2021 · The final results from a Grail study of its cancer-tracing blood test found it was accurate at detecting a range of different tumors at early stages—especially those more likely to be lethal and ha
Edwards excites with Evoque FDA approval in transcatheter …
WEBFeb 2, 2024 · Edwards received a CE mark in Europe that same month, marking the first regulatory approval for a minimally invasive therapy to tackle the historically tricky tricuspid valve. With its set of ...
CRO - Fierce Biotech
WEBPharmaLegacy snaps up preclinical CRO. PharmaLegacy Laboratories is snapping up BTS Research in hopes of expanding its reach as a preclinical CRO. Gabrielle Masson Sep 16, 2024 3:50pm. Connect ...